BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $18.5B
- YoY, 2025
- +13.1%
- 5-year CAGR
- −13.4%
- 10-year CAGR
- +2.6%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $18.5B | +13.1% |
| 2024 | $16.3B | −44.5% |
| 2023 | $29.4B | −5.3% |
| 2022 | $31.1B | −13.6% |
| 2021 | $35.9B | −5.0% |
| 2020 | $37.8B | −26.7% |
| 2019 | $51.6B | +267.7% |
| 2018 | $14.0B | +19.5% |
| 2017 | $11.7B | −27.4% |
| 2016 | $16.2B | +13.4% |
| 2015 | $14.3B | −3.9% |
| 2014 | $14.9B | −2.0% |
| 2013 | $15.2B | +11.2% |
| 2012 | $13.6B | −14.6% |
| 2011 | $16.0B | +1.5% |
| 2010 | $15.7B | +5.9% |
| 2009 | $14.8B | +21.3% |
| 2008 | $12.2B | — |